Do the risks of Lynch syndrome-related cancers depend on the parent of origin of the mutation?

Abstract:

:Individuals who carry pathogenic mutations in DNA mismatch repair (MMR) genes have high risks of cancer, and small studies have suggested that these risks depend on the sex of the parent from whom the mutation was inherited. We have conducted the first large study of such a parent-of-origin effect (POE). Our study was based on all MMR gene mutation carriers and their relatives in the Colon Cancer Family Registry, comprising 18,226 people. The POE was estimated as a hazard ratio (HR) using a segregation analysis approach that adjusted for ascertainment. HR = 1 corresponds to no POE and HR > 1 corresponds to higher risks for maternal mutations. For all MMR genes combined, the estimated POE HRs were 1.02 (95% confidence interval (CI) 0.75-1.39, p = 0.9) for male colorectal cancer, 1.12 (95% CI 0.81-1.54, p = 0.5) for female colorectal cancer and 0.84 (95% CI 0.52-1.36, p = 0.5) for endometrial cancer. Separate results for each MMR gene were similar. Therefore, despite being well-powered, our study did not find any evidence that cancer risks for MMR gene mutation carriers depend on the parent-of-origin of the mutation. Based on current evidence, we do not recommend that POEs be incorporated into the clinical guidelines or advice for such carriers.

journal_name

Fam Cancer

journal_title

Familial cancer

authors

Gemechu SD,van Vliet CM,Win AK,Figueiredo JC,Le Marchand L,Gallinger S,Newcomb PA,Hopper JL,Lindor NM,Jenkins MA,Dowty JG

doi

10.1007/s10689-020-00167-4

subject

Has Abstract

pub_date

2020-07-01 00:00:00

pages

215-222

issue

3

eissn

1389-9600

issn

1573-7292

pii

10.1007/s10689-020-00167-4

journal_volume

19

pub_type

杂志文章
  • Pain evaluation during gynaecological surveillance in women with Lynch syndrome.

    abstract::To evaluate perceived pain during repetitive annual endometrial sampling at gynaecologic surveillance in asymptomatic women with Lynch syndrome (LS) over time and in addition to symptomatic women without LS, undergoing single endometrial sampling. In this prospective study, 52 women with LS or first degree relatives w...

    journal_title:Familial cancer

    pub_type: 杂志文章

    doi:10.1007/s10689-016-9937-x

    authors: Helder-Woolderink J,de Bock G,Hollema H,van Oven M,Mourits M

    更新日期:2017-04-01 00:00:00

  • Association of MUTYH and MSH6 germline mutations in colorectal cancer patients.

    abstract::Colorectal cancer (CRC) risk associated with germline monoallelic MUTYH mutations remains controversial, although a slightly increased risk for this disease has been suggested. MUTYH and MSH6 proteins act in cooperation during the DNA repair process. Based on this interaction, it was hypothesized that the combination ...

    journal_title:Familial cancer

    pub_type: 杂志文章

    doi:10.1007/s10689-009-9282-4

    authors: Giráldez MD,Balaguer F,Caldés T,Sanchez-de-Abajo A,Gómez-Fernández N,Ruiz-Ponte C,Muñoz J,Garre P,Gonzalo V,Moreira L,Ocaña T,Clofent J,Carracedo A,Andreu M,Jover R,Llor X,Castells A,Castellví-Bel S,Gastrointestinal O

    更新日期:2009-01-01 00:00:00

  • Restorative proctocolectomy and ileal pouch-anal anastomosis for familial adenomatous polyposis revisited.

    abstract::Since restorative proctocolectomy (RPC) with ileal-pouch anal anastomosis (IPAA) removes the entire diseased mucosa, it has become firmly established as the standard operative procedure of choice for familial adenomatous polyposis (FAP). Many technical controversies still persist, such as mesenteric lengthening techni...

    journal_title:Familial cancer

    pub_type: 杂志文章,评审

    doi:10.1007/s10689-005-5672-4

    authors: Kartheuser A,Stangherlin P,Brandt D,Remue C,Sempoux C

    更新日期:2006-01-01 00:00:00

  • Screening of 1331 Danish breast and/or ovarian cancer families identified 40 novel BRCA1 and BRCA2 mutations.

    abstract::Germ-line mutations in the tumour suppressor genes BRCA1 and BRCA2 predispose to breast and ovarian cancer. Since 1999 we have performed mutational screening of breast and/or ovarian cancer patients in East Denmark. During this period we have identified 40 novel sequence variations in BRCA1 and BRCA2 in high risk brea...

    journal_title:Familial cancer

    pub_type: 杂志文章

    doi:10.1007/s10689-011-9422-5

    authors: Hansen TV,Jønson L,Steffensen AY,Andersen MK,Kjaergaard S,Gerdes AM,Ejlertsen B,Nielsen FC

    更新日期:2011-06-01 00:00:00

  • Epitope-positive truncating MLH1 mutation and loss of PMS2: implications for IHC-directed genetic testing for Lynch syndrome.

    abstract::We assessed mismatch repair by immunohistochemistry (IHC) and microsatellite instability (MSI) analysis in an early onset endometrial cancer and a sister's colon cancer. We demonstrated high-level MSI and normal expression for MLH1, MSH2 and MSH6. PMS2 failed to stain in both tumors, strongly implicating a PMS2 defect...

    journal_title:Familial cancer

    pub_type: 杂志文章

    doi:10.1007/s10689-009-9276-2

    authors: Zighelboim I,Powell MA,Babb SA,Whelan AJ,Schmidt AP,Clendenning M,Senter L,Thibodeau SN,de la Chapelle A,Goodfellow PJ

    更新日期:2009-01-01 00:00:00

  • The 1100delAT BRCA1 and the 8765delAG BRCA2 mutations: occurrence in high-risk non-Ashkenazi Jews and haplotype comparison of Jewish and non-Jewish carriers.

    abstract::Few mutations have been described in BRCA1 and BRCA2 in high-risk non-Ashkenazi Jews. In a Libyan family the 1100delAT BRCA1 mutation was detected and the 8765delAG BRCA2 mutation was previously described in two Jewish-Yemenite-families. In this study, the rate of these mutations in high-risk Jews of North African and...

    journal_title:Familial cancer

    pub_type: 杂志文章

    doi:10.1023/B:FAME.0000026837.32470.b4

    authors: Gal I,Gershoni Baruch R,Haber D,Dagan E,Eisenberg-Barzilai S,Zidan J,Friedman E

    更新日期:2004-01-01 00:00:00

  • Screening behavior in women at increased familial risk for breast cancer.

    abstract::This multicenter study examined the adherence of high-risk women to screening recommendations for breast and ovarian cancer following consultation at a familial cancer clinic (FCC). Self-report questionnaires assessing recall of screening advice, tests undertaken, risk perception, anxiety (Impact of Events Scale) and ...

    journal_title:Familial cancer

    pub_type: 杂志文章,多中心研究

    doi:10.1007/s10689-006-0006-8

    authors: Antill YC,Reynolds J,Young MA,Kirk JA,Tucker KM,Bogtstra TL,Wong SS,Dudding TE,Di Iulio JL,Phillips KA

    更新日期:2006-01-01 00:00:00

  • Lynch syndrome: the influence of environmental factors on extracolonic cancer risk in hMLH1 c.C1528T mutation carriers and their mutation-negative sisters.

    abstract::Lynch Syndrome (LS) is a cancer susceptibility syndrome caused mostly by mutations in the mismatch repair genes, hMLH1, hMSH2 and hMSH6. Mutation carriers are at risk of colorectal and endometrial cancer and, less frequently, cancer of the ovaries, stomach, small bowel, hepatobiliary tract, ureter, renal pelvis and br...

    journal_title:Familial cancer

    pub_type: 杂志文章

    doi:10.1007/s10689-010-9334-9

    authors: Blokhuis MM,Pietersen GE,Goldberg PA,Algar U,Van der Merwe L,Mbatani N,Vorster AA,Ramesar RS

    更新日期:2010-09-01 00:00:00

  • Cancer genetic predisposition: information needs of patients irrespective of risk level.

    abstract::Increased insight into the information needs of people about cancer genetic predisposition could allow materials to be developed to improve decision-making for those at high risk, whilst those at lower risk could have their anxiety reduced without the need for referral to genetics services. This study aimed to identif...

    journal_title:Familial cancer

    pub_type: 杂志文章

    doi:10.1007/s10689-009-9256-6

    authors: Metcalfe A,Werrett J,Burgess L,Chapman C,Clifford C

    更新日期:2009-01-01 00:00:00

  • Two cases of somatic STK11 mosaicism in Danish patients with Peutz-Jeghers syndrome.

    abstract::Peutz-Jeghers syndrome (PJS) is a hereditary polyposis syndrome characterized by hamartomatous Peutz-Jeghers polyps in the gastrointestinal tract, mucocutaneous pigmentations, and increased risk for intestinal and extraintestinal cancer. In more than two-third of patients it is possible to detect pathogenic variants i...

    journal_title:Familial cancer

    pub_type: 杂志文章

    doi:10.1007/s10689-020-00191-4

    authors: Jelsig AM,Bertelsen B,Forss I,Karstensen JG

    更新日期:2020-06-06 00:00:00

  • Sarcoma in neurofibromatosis 2: case report and review of the literature.

    abstract::Neurofibromatosis type 2 (NF2) is associated with the development of several types of benign nervous system tumours, while malignancies are rare. We report a 22-year-old man who presented with retroperitoneal and spinal high-grade sarcomas with epithelial features. Samples showed a mixed epithelioid and spindled cell ...

    journal_title:Familial cancer

    pub_type: 杂志文章,评审

    doi:10.1007/s10689-018-0084-4

    authors: Linder C,Smith MJ,Bulman M,Wallace A,Freemont AJ,Mangham DC,Evans DGR

    更新日期:2019-01-01 00:00:00

  • Inequities in multi-gene hereditary cancer testing: lower diagnostic yield and higher VUS rate in individuals who identify as Hispanic, African or Asian and Pacific Islander as compared to European.

    abstract::The identification of germline pathogenic/likely pathogenic (P/LP) variants in cancer predisposition genes can guide treatment and management decisions for the individual being tested and potentially at-risk relatives. Prior studies have raised concerns of racial/ethnic disparities in the detection rates of P/LP varia...

    journal_title:Familial cancer

    pub_type: 杂志文章

    doi:10.1007/s10689-019-00144-6

    authors: Ndugga-Kabuye MK,Issaka RB

    更新日期:2019-10-01 00:00:00

  • Lynch Syndrome in high risk Ashkenazi Jews in Israel.

    abstract::Lynch Syndrome is caused by mutations in DNA mismatch repair genes. Diagnosis is not always trivial and may be costly. Information regarding incidence, genotype-phenotype correlation, spectrum of mutations and genes involved in specific populations facilitate the diagnostic process and contribute to clinical work-up. ...

    journal_title:Familial cancer

    pub_type: 杂志文章

    doi:10.1007/s10689-013-9675-2

    authors: Goldberg Y,Kedar I,Kariiv R,Halpern N,Plesser M,Hubert A,Kaduri L,Sagi M,Lerer I,Abeliovich D,Hamburger T,Nissan A,Goldshmidt H,Solar I,Geva R,Strul H,Rosner G,Baris H,Levi Z,Peretz T

    更新日期:2014-03-01 00:00:00

  • Psychological impact of genetic counseling for familial cancer: a systematic review and meta-analysis.

    abstract:BACKGROUND:Identification of a genetic basis underlying certain types of cancer has led to an increase in demand for genetic counseling about individual risks of the disease. We conducted a systematic review of the literature to determine the quality and strength of evidence relating to psychological outcomes of geneti...

    journal_title:Familial cancer

    pub_type: 杂志文章,meta分析,评审

    doi:10.1007/s10689-005-2577-1

    authors: Braithwaite D,Emery J,Walter F,Prevost AT,Sutton S

    更新日期:2006-01-01 00:00:00

  • Chemoprevention with special reference to inherited colorectal cancer.

    abstract::Familial Adenomatous Polyposis (FAP) is a model for the adenoma-carcinoma sequence in several respects. One important area in which FAP serves as a model is chemoprevention. Early prevention trials mainly utilized micronutrients and were largely unsuccessful in preventing or causing regression of adenomas. A new era w...

    journal_title:Familial cancer

    pub_type: 杂志文章

    doi:10.1007/s10689-007-9158-4

    authors: Lynch PM

    更新日期:2008-01-01 00:00:00

  • Uptake of predictive testing among relatives of BRCA1 and BRCA2 families: a multicenter study in northeastern Spain.

    abstract::Identifying a BRCA mutation among families with hereditary breast and ovarian cancer enables distinguishing those who may benefit from a specific medical management. This study aimed to evaluate the uptake of predictive testing among close relatives of a proband in Spanish families with a BRCA1 or BRCA2 mutation, and ...

    journal_title:Familial cancer

    pub_type: 杂志文章,多中心研究

    doi:10.1007/s10689-009-9313-1

    authors: Sanz J,Ramón y Cajal T,Torres A,Darder E,Gadea N,Velasco A,Fortuny D,López C,Fisas D,Brunet J,Alonso MC,Balmaña J

    更新日期:2010-09-01 00:00:00

  • Cancer risks and immunohistochemical profiles linked to the Danish MLH1 Lynch syndrome founder mutation.

    abstract::Founder mutations with a large impact in distinct populations have been described in Lynch syndrome. In Denmark, the MLH1 c.1667+2_1667_+8TAAATCAdelinsATTT mutation accounts for 25 % of the MLH1 mutant families. We used the national Danish hereditary nonpolyposis colorectal cancer register to estimate the cumulative l...

    journal_title:Familial cancer

    pub_type: 杂志文章

    doi:10.1007/s10689-012-9552-4

    authors: Therkildsen C,Isinger-Ekstrand A,Ladelund S,Nissen A,Rambech E,Bernstein I,Nilbert M

    更新日期:2012-12-01 00:00:00

  • Uroepithelial and kidney carcinoma in Lynch syndrome.

    abstract::Increased risk for urological tumors has been observed in mutation carriers with Lynch syndrome (LS). In this study, we evaluated the clinical features of uroepithelial (bladder and ureter) and kidney cancers in 974 Finnish mutation carriers. Altogether 30 patients had a total of 34 urological tumors: 12 ureter, 12 bl...

    journal_title:Familial cancer

    pub_type: 杂志文章

    doi:10.1007/s10689-012-9526-6

    authors: Aarnio M,Säily M,Juhola M,Gylling A,Peltomäki P,Järvinen HJ,Mecklin JP

    更新日期:2012-09-01 00:00:00

  • Uptake of genetic counseling, genetic testing and surveillance in hereditary malignant melanoma (CDKN2A) in Norway.

    abstract::Germline mutations in the CDKN2A gene are associated with an increased risk of malignant melanoma and pancreatic cancer. In order to find out if the behavior pattern in families with a CDKN2A mutation is similar to what we previously have described in families with a BRCA1 mutation, we have studied the uptake of genet...

    journal_title:Familial cancer

    pub_type: 杂志文章

    doi:10.1007/s10689-016-9939-8

    authors: Levin T,Mæhle L

    更新日期:2017-04-01 00:00:00

  • Identification of a rare germline NBN gene mutation by whole exome sequencing in a lung-cancer survivor from a large family with various types of cancer.

    abstract::Nijmegen breakage syndrome is an autosomal recessive disorder caused by biallelic mutation in NBN gene. It is characterized by microcephaly, growth retardation, immuno-deficiency and cancer predisposition. The monoallelic carriers of NBN gene are also reported to be at increased risk of developing various types of mal...

    journal_title:Familial cancer

    pub_type: 杂志文章

    doi:10.1007/s10689-016-9954-9

    authors: Marafie MJ,Dashti M,Al-Mulla F

    更新日期:2017-07-01 00:00:00

  • Hereditary medullary thyroid carcinoma: the management dilemma.

    abstract::Hereditary medullary thyroid carcinoma (hereditary MTC) is a rare malignancy, accounting for 25-30% of all MTC. It occurs as part of multiple endocrine neoplasia type 2 (MEN 2). Autosomal dominant gain-of-function mutations in the RET proto-oncogene is the cause of the disease, in which the common mutations are codons...

    journal_title:Familial cancer

    pub_type: 杂志文章,评审

    doi:10.1007/s10689-011-9501-7

    authors: Zhou P,Liu J,Cheng SW,Wang B,Yang R,Peng L

    更新日期:2012-06-01 00:00:00

  • Breast and ovarian cancer risk management in a French cohort of 158 women carrying a BRCA1 or BRCA2 germline mutation: patient choices and outcome.

    abstract::Description of the various modalities of breast and ovarian cancer risk management, patient choices and their outcome in a single-center cohort of 158 unaffected women carrying a BRCA1 or BRCA2 germline mutation. Between 1998 and 2009, 158 unaffected women carrying a BRCA1 or BRCA2 gene mutation were prospectively fol...

    journal_title:Familial cancer

    pub_type: 临床试验,杂志文章

    doi:10.1007/s10689-012-9539-1

    authors: This P,de la Rochefordière A,Savignoni A,Falcou MC,Tardivon A,Thibault F,Alran S,Fourchotte V,Fitoussi A,Couturaud B,Dolbeault S,Salmon RJ,Sigal-Zafrani B,Asselain B,Stoppa-Lyonnet D,Institut Curie Breast and Ovarian Cancer

    更新日期:2012-09-01 00:00:00

  • Response to neo-adjuvant chemotherapy in BRCA1 and BRCA2 related stage III breast cancer.

    abstract::Pathological features and consequently, tumor response differ between BRCA1/2 carriers and sporadic breast cancer (BC) cases. It is expected that BRCA1/2 associated tumors will be more vulnerable to DNA damaging agents and irradiation due to their function in DNA repair. In addition, very high pathological complete re...

    journal_title:Familial cancer

    pub_type: 杂志文章

    doi:10.1007/s10689-008-9223-7

    authors: Hubert A,Mali B,Hamburger T,Rottenberg Y,Uziely B,Peretz T,Kadouri L

    更新日期:2009-01-01 00:00:00

  • Disclosing cancer genetic information within families: perspectives of counselees and their at-risk relatives.

    abstract:PURPOSE:The aim of the present descriptive study was to investigate the experience of sharing genetic information among cancer genetic counselees and their at-risk relatives. METHODS:In total, 147 cancer genetic counselees and 81 of their at-risk relatives answered to a study specific questionnaire and/or were intervi...

    journal_title:Familial cancer

    pub_type: 杂志文章

    doi:10.1007/s10689-010-9364-3

    authors: Hayat Roshanai A,Lampic C,Rosenquist R,Nordin K

    更新日期:2010-12-01 00:00:00

  • Standards of care in diagnosis and testing for hereditary colon cancer.

    abstract::Inherited colorectal cancer predisposition involves a rather heterogeneous range of rare, yet relatively well-defined disorders, including Familial Adenomatous Polyposis (FAP), Hereditary Non-polyposis Colorectal Cancer (HNPCC) or Lynch syndrome, Peutz-Jeghers syndrome, Juvenile Polyposis, and their respective variant...

    journal_title:Familial cancer

    pub_type: 杂志文章

    doi:10.1007/s10689-007-9159-3

    authors: Lynch PM

    更新日期:2008-01-01 00:00:00

  • Risk management adherence following genetic testing for hereditary cancer syndromes: a Singaporean experience.

    abstract::Assessing adherence behavior among mutation carriers to cancer risk management guidelines is important for both service improvement and cost-effectiveness analyses, but such real-world data is often lacking. The present study aims to report adherence rates among mutation carriers in a recently established cancer genet...

    journal_title:Familial cancer

    pub_type: 杂志文章

    doi:10.1007/s10689-018-0071-9

    authors: Courtney E,Chin XW,Yuen J,Li ST,Chen Y,Allen JC Jr,Tan V,Lim GH,Ngeow J

    更新日期:2018-10-01 00:00:00

  • Occurrence of both breast and ovarian cancer in a woman is a marker for the BRCA gene mutations: a population-based study from western Sweden.

    abstract:AIM:This study aimed to analyze whether the occurrence of both breast and ovarian cancer in a woman serves as a marker for BRCA gene mutations. MATERIAL AND METHODS:This population-based study included 256 women in western Sweden who developed both invasive breast and ovarian tumors between 1958 and 1999. Archival par...

    journal_title:Familial cancer

    pub_type: 杂志文章

    doi:10.1007/s10689-006-9101-0

    authors: Einbeigi Z,Bergman A,Meis-Kindblom JM,Flodin A,Bjursell C,Martinsson T,Kindblom LG,Wahlström J,Wallgren A,Nordling M,Karlsson P

    更新日期:2007-01-01 00:00:00

  • Hereditary ovarian cancer in Ashkenazi Jews.

    abstract::Ovarian cancer is the fourth leading cause of cancer deaths among American women. While women in both the Ashkenazi and non-Ashkenazi populations have an estimated 1.7% lifetime risk of acquiring malignancy, the proportion of hereditary ovarian cancer is much higher in the Ashkenazim. Most of this increased proportion...

    journal_title:Familial cancer

    pub_type: 杂志文章,评审

    doi:10.1007/s10689-004-9552-0

    authors: Robles-Díaz L,Goldfrank DJ,Kauff ND,Robson M,Offit K

    更新日期:2004-01-01 00:00:00

  • CTNNB1-mutant colorectal carcinomas with immediate invasive growth: a model of interval cancers in Lynch syndrome.

    abstract::The implementation of regular colonoscopy programs has significantly decreased the mortality associated with colorectal cancer (CRC) in Lynch syndrome patients. However, interval CRCs in Lynch syndrome that remain undetected by colonoscopy still represent a substantial problem in the management of the syndrome. One po...

    journal_title:Familial cancer

    pub_type: 杂志文章

    doi:10.1007/s10689-016-9899-z

    authors: Ahadova A,von Knebel Doeberitz M,Bläker H,Kloor M

    更新日期:2016-10-01 00:00:00

  • Characterization of BRCA1 and BRCA2 variants found in a Norwegian breast or ovarian cancer cohort.

    abstract::Germline mutations in BRCA1 and BRCA2 cause hereditary breast and ovarian cancer. Molecular screening of these two genes in patients with a family history of breast or ovarian cancer has revealed pathogenic variants as well as genetic variants of unknown significance (VUS). These VUS may cause a challenge in the genet...

    journal_title:Familial cancer

    pub_type: 杂志文章

    doi:10.1007/s10689-016-9916-2

    authors: Jarhelle E,Riise Stensland HM,Mæhle L,Van Ghelue M

    更新日期:2017-01-01 00:00:00